Recurrent Giant Phyllodes Tumour of the Breast Pathological Considerations and Management Approach for Recurrence and Metastasis

Norman Oneil Machado

Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman.

DOI: 10.4236/ss.2012.34043                

Abstract

Phyllodes tumours are rare and account for 0.4% of all breast tumours. The majority of them tend to be less than 5 cms in size with giant tumours larger than 10 cms being about 20% of these cases. They display a broad range of clinical and pathological behavior and are regarded as falling within the spectrum of fibroepithelial neoplasms. Surgery has been the primary modality of treatment. However the extent of resection and the role of adjuvant radiotherapy and chemotherapy are still controversial. The risk of recurrence is (4.7% - 30%) for benign phyllodes tumour and (30% - 65%) for borderline and malignant phyllodes tumour. A case of giant phyllodes tumour measuring 36 × 30 cm and weighing 6.8 kg is presented, which had recurred following a previous resection 5 years back. The literature is reviewed with regards to pathology, the role of investigations, nature of resection and the risk factors for recurrence and metastasis

Keywords

Phyllodes Tumour, Mastectomy, Giant Tumour, Recurrence

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	S. J. Parker and S. A. Harries, “Phyllodes Tumours,” Postgraduate Medical Journal, Vol. 77, 909, 2001, pp. 428-435. doi:10.1136/pmj.77.909.428
[2]	M. Pandey, A. Mathew, J. Kattor, E. K. Abraham, B. S. Mathew, B. Rajan and K. M. Nair, “Malignant Phyllodes Tumours,” Breast Journal, Vol. 7, No. 6, 2001, pp. 411-4116. doi:10.1046/j.1524-4741.2001.07606.x
[3]	W. H. Chen, S. P. Cheng, C. Y. Tzen, T. L. Yang, K. S. Jeng, C. L. Liu and T. P. Liu, “Surgical Treatment of Phyllodes Tumours of the Breast. Retrospective Review of 172 Cases,” Journal of Surgical Oncology, Vol. 91, No. 3, 2005, pp. 185-194.
[4]	J. Ben Hassouna, T. Damak, A. Gamoudi, R. Chargui, F. Khomsi, S. Mahjoub, et al., “Phyllodes Tumours of the Breast: A Case Series of 106 Patients,” American Journal of Surgery, Vol. 192, No. 2, 2006, pp. 141-147. doi:10.1016/j.amjsurg.2006.04.007
[5]	M. Pietruszka and L. Barnes, “Cystosarcoma Phyllodes. A Clinicopathologic Analysis of 42 Cases,” Cancer, Vol. 41, No. 5, 1978, pp. 1974-1983. doi:10.1002/1097-0142(197805)41:5<1974::AID-CNCR2820410543>3.0.CO;2-C
[6]	C. Walravens and C. De Greef, “Giant Phyllodes tumour of the Breast,” Journal of Plastic, Reconstructive & Aesthetic Surgery, Vol. 61, No. 10, 2008, pp. e9-e11. doi:10.1016/j.bjps.2007.10.018
[7]	N. Matar, A. Soumani, M. Noun, T. Chraibi, A. Himmi, A. El Mansouri, et al., “Phyllodes Tumour of the Breast. Forty One Cases,” Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, Vol. 26, No. 1, 1997, pp. 32-36.
[8]	J. F. Stebbing and A. G. Nash, “Diagnosis and Management of Phyllodes Tumour of the Breast: Experience of 33 Cases at a Specialist Center,” Annals of the Royal College of Surgeons of England, Vol. 77, No. 3, 1995, pp. 181-184.
[9]	L. M. Foxcroft, E. B. Evans and A. J. Porter, “Difficulties in the Pre-Operative Diagnosis of Phyllodes Tumour of the Breast: A Study of 84 Cases,” Breast, Vol. 16, No. 1, 2007, pp. 27-37. doi:10.1016/j.breast.2006.05.004
[10]	M. K. Bode, T. Rissanen and M. Apaja-Sarikkinen, “Ultrasonography and Core Needle Biopsy in the Differential Diagnosis of Fibroadenoma and Tumour Phyllodes,” Acta Radiologica, Vol. 48, No. 7, 2007, pp. 708-713. doi:10.1080/02841850701367911
[11]	P. De Albertis, M. Oliveri, P. Quadri, G. Serafini, A. Cavallo, O. Orlando, et al., “Retrospective Analysis of Color Doppler Ultrasonography and Flowmetry Findings in Solid Nodular Pathology of the Breast,” Radiology Medicine, Vol. 89, No. 1-2, 1995, pp. 28-35.
[12]	M. Takahashi, K. Murata, M. Mori, N. Kawaguchi, A. Furukawa, R. Kushima and R. Morita, “Giant Metastatic Cystosarcoma Phyllodes to the Lung: CT and MR Findings,” Radiation Medicine, Vol. 10, No. 5, 1992, pp. 210-213.
[13]	S. Krishnamurthy, R. Ashfaq, H. J. Shin and N. Sneige, “Distinction of Phyllodes Tumour from Fibroadenoma: A Reappraisal of an Old Problem,” Cancer, Vol. 90, No. 6, 2000, pp. 342-349. doi:10.1002/1097-0142(20001225)90:6<342::AID-CNCR4>3.0.CO;2-I
[14]	G. Cohn-Cedermark, L. E. Rutqvist, I. Rosendahl and C. Silfversward, “Prognostic Factors in Cystosarcoma Phyllodes. A Clinicopathological Study of 77 Patients,” Cancer, Vol. 68, No. 9, 1991, pp. 2017-2022. doi:10.1002/1097-0142(19911101)68:9<2017::AID-CNCR2820680929>3.0.CO;2-V
[15]	A. W. Chaney, A. Pollack, M. D. McNeese , G. K. Zagars, P. W. Pisters, R. E. Pollock, et al., “Primary Treatment of Cystosarcoma Phyllodes of the Breast,” Cancer, Vol. 89, No. 7, 2000, pp. 1502-1511. doi:10.1002/1097-0142(20001001)89:7<1502::AID-CNCR13>3.0.CO;2-P
[16]	H. J. Norris and H. B. Taylor, “Relationship of Histologic Features to Behavior of Cystosarcoma Phyllodes, Analysis of Ninety-Four Cases,” Cancer, Vol. 20, No. 12, 1967, pp. 2090-2099. doi:10.1002/1097-0142(196712)20:12<2090::AID-CNCR2820201206>3.0.CO;2-L
[17]	B. Salvadori, F. Cusumano, R. Del Bo, V. Delledonne, M. Grassi, D. Rovini, et al., “Surgical Treatment of Phyllodes Tumour of the Breast,” Cancer, Vol. 63, No. 12, 1989, pp. 2532-2536. doi:10.1002/1097-0142(19890615)63:12<2532::AID-CNCR2820631229>3.0.CO;2-Q
[18]	R. W. McDivitt, J. A. Urban and J. H. Farrow, “Cystosarcoma Phyllodes,” Johns Hopkins Medical Journal, Vol. 120, No. 1, 1967, pp. 33-45.
[19]	M. Lenhard, S. Kahlert, I. Himsi, et al., “Phyllodes Tumour of the Breast: Clinical Follow-Up of 33 Cases of This Rare Disease,” European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 138, No. 2, 2007, pp. 217-221. doi:10.1016/j.ejogrb.2007.08.002
[20]	A. Barrio, B. Clark, J. Goldberg, et al., “Clinicopathologic Features and Long Term Outcomes of 293 Phyllodes Tumour of the Breast,” Annals of Surgical Oncology, Vol. 14, No. 10, 2007, pp. 2961-2970. doi:10.1245/s10434-007-9439-z
[21]	N. Taira, D. Takabatake, K. Aogi, et al., “Phyllodes Tumour of the Breast: Stromal Overgrowth and Histological Classification Are Useful Prognosis-Predictive Factors for Local Recurrence in Patients with a Positive Surgical Margin,” Japanese Journal of Clinical Oncology, Vol. 37, No. 10, 2007, pp. 730-736. doi:10.1093/jjco/hym099
[22]	H. Abdalla and M. Sakr, “Predictive Factors of Local Recurrence and Survival Following Primary Surgical Treatment of Phyllodes Tumour of the Breast,” Journal of the Egyptian National Cancer Institute, Vol. 18, No. 2, 2006, pp. 125-133.
[23]	A. Fou, F. Schnabel, D. Hamele-Bena, et al., “Long Term Outcomes of Malignant Phyllodes Tumours Patients: An Institutional Experience,” American Journal of Surgery, Vol. 192, No. 4, 2006, pp. 492-495. doi:10.1016/j.amjsurg.2006.06.017
[24]	K. Kok, P. Telesinghe and S. Yapp, “Treatment and Outcome of Cystosarcoma Phyllodes in Brunei: A 13 Year Experience,” Journal of the Royal College of Surgeons of Edinburgh, Vol. 46, No. 4, 2001, pp. 198-201.
[25]	I. Kapiris, N. Nasir, R. A’hern, V. Healy and G. Gui, “outcome and Predictive Factors of Local Recurrence and Distant Metastasis Following Primary Surgical Treatment of High Grade Malignant Phyllodes Tumours of the Breast,” European Journal of Surgical Oncology, Vol. 27, No. 5, 2001, pp. 723-730. doi:10.1053/ejso.2001.1207
[26]	A. Chaney, A. Pollack, M. McNeese, et al., “Primary Treatment of Cyst Sarcoma Phloxes of the Breast,” Cancer, Vol. 89, No. 7, 2000, pp. 1502-1511. doi:10.1002/1097-0142(20001001)89:7<1502::AID-CNCR13>3.0.CO;2-P
[27]	D. Holthouse, P. Smith, R. Naunton-Morgon and D. Minchin, “Cystosarcoma Phyllodes: The Western Australian Experience,” Australian and New Zealand Journal of Surgery, Vol. 69, No. 9, 1999, pp. 635-638. doi:10.1046/j.1440-1622.1999.01654.x
[28]	C. Zissis, N. Apostolikas, A. Konstantinidou, J. Griniatsos and P. Vassilopoulas, “The Extent of Surgery and Prognosis of Patients with Phyllodes Tumour of the Breast,” Breast Cancer Research and Treatment, Vol. 48, No. 3, 1998, pp. 205-210. doi:10.1023/A:1005980831359
[29]	W. de Roos, P. Kaye and D. Dent, “Factors Leading to Local Recurrence or Death after Surgical Resection of Phyllodes Tumours of the Breast,” British Journal of Surgery, Vol. 86, No. 3, 1999, pp. 396-399. doi:10.1046/j.1365-2168.1999.01035.x
[30]	M. Reinfuss, J. Mitus, K. Duda, et al., “The Treatment and Prognosis of Patients with Phyllodes Tumour of the Breast,” Cancer, Vol. 77, 1996, pp. 910-916.
[31]	O. Asoglu, M. Ugurlu, K. Blanchard, et al., “Risk Factors for Recurrence and Death after Primary Surgical Treatment of Malignant Phyllodes Tumours,” Annals of Surgical Oncology, Vol. 11, No. 11, 2004, pp. 1011-1017. doi:10.1245/ASO.2004.02.001
[32]	R. Soumarova, Z. Seneklova, H. Horova, H. Vojkovska, I. Horova, M. Budikova, J. Ruzickova and B. Jezkova, “Retrospective Analysis of 25 Women with Malignant Cystosarcoma Phyllodes-Treatment Results,” Archives of Gynecology and Obstetrics, Vol. 269, No. 4, 2004, pp. 278-281. doi:10.1007/s00404-003-0593-7
[33]	R. J. Barth, W. A. Wells, S. E. Mitchell and B. F. Cole, “A Prospective Multi-Institutional Study of Adjuvant Radiotherapy after Resection of Malignant Phyllodes Tumours,” Annals of Surgical Oncology, Vol. 16, No. 8, 2009, pp. 2288-2294. doi:10.1245/s10434-009-0489-2